Bispecific Nanobodies As a Therapeutic for Alzheimer's Disease

The present invention provides for the treatment of Alzheimer's disease. More specifically, a recombinant bispecific antibody fragment that simultaneously blocks beta-secretase activity while also promoting alpha-secretase activity, comprising a first portion and a second portion, wherein the first portion blocks beta secretase activity and the second portion promotes alpha-secretase activity.

Patents:
WO 2,011,031,720

Inventor(s): SIERKS MICHAEL [US]; BODDAPATI SHANTA [US]; KASTURIRANGAN SRINATH [US]

Type of Offer: Licensing



« More Medical Patents

---